AlphaMeld
About

AI augments scientific judgment — it doesn't replace it.

AlphaMeld is built on a simple bet: the biggest leverage in drug discovery isn't more data — it's better reasoning over the data we already have. We augment your scientists; we don't replace them.

By design

Modality-agnostic.

Whether the right asset is a small molecule, antibody, peptide, ADC, or gene therapy, AlphaMeld reasons over the same biological substrate. The right therapeutic format for each program emerges from the data — not the toolkit a partner walked in with.

Small molecules

Hit-ID, lead optimization, IP runway

Biologics

Antibody design and ADC payload selection

Peptides

Targeted formats and stability engineering

Gene & cell

Disease-mechanism-aligned target nomination

Capabilities

Eight curated agents. One orchestration layer. Each runs as a FastAPI workflow with a deterministic interface.

C.01

Knowledge graph reasoning

Multi-hop traversal across targets, diseases, drugs, endpoints, and pathways.

C.02

Target identification

Genetic, druggability, IP, and safety priors triangulated into ranked candidate lists.

C.03

Indication discovery

From a single target, surface and prioritize additional indications.

C.04

Hypothesis validation

Stress-test hypotheses against KG and literature; produce a diligence dossier.

C.05

Trial design

Endpoint selection, phase-transition prediction, and competitor-aware positioning.

C.06

TPP audit

Compare defined Target Product Profiles against actual readouts; surface drift.

C.07

Safety assessment

On- and off-target liabilities, population signals, and competitor safety benchmarks.

C.08

Reports synthesis

Templated, diligence-grade reports with full provenance and source linking.

Mission

Who we are

AlphaMeld is a drug-discovery operating system for pharma R&D. We unify a 1.97B-edge biomedical knowledge graph, curated scientific agents, and live trial intelligence into one orchestrated, evidence-linked system — so research teams compress target ID, validation, and TPP design from quarters into days.

Culture

How we work

We pair drug-discovery scientists with the AI engineers building the platform underneath them. Every claim ships with its evidence trail; every agent is auditable; every workflow is reproducible. We hire for that bar, and we collaborate with partners who hold their R&D to the same standard.

Get started

Ready to compress your discovery timelines?

See AlphaMeld run a live target-discovery workflow on your therapy area in 30 minutes.